Pa. Clarke et al., Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential, BIOCH PHARM, 62(10), 2001, pp. 1311-1336
With the imminent completion of the Human Genome Project, biomedical resear
ch is being revolutionised by the ability to carry out investigations on a
genome wide scale. This is particularly important in cancer, a disease that
is caused by accumulating abnormalities in the sequence and expression of
a number of critical genes. Gene expression microarray technology is gainin
g increasingly widespread use as a means to determine the expression of pot
entially all human genes at the level of messenger RNA. In this commentary,
we review developments in gene expression microarray technology and illust
rate the progress and potential of the methodology in cancer biology, pharm
acology, and drug development. Important applications include: (a) developm
ent of a more global understanding of the gene expression abnormalities tha
t contribute to malignant progression; (b) discovery of new diagnostic and
prognostic indicators and biomarkers of therapeutic response; (c) identific
ation and validation of new molecular targets for drug development; (d) pro
vision of an improved understanding of the molecular mode of action during
lead identification and optimisation, including structure-activity relation
ships for on-target versus off-target effects; (e) prediction of potential
side-effects during preclinical development and toxicology studies; (f) con
firmation of a molecular mode of action during hypothesis-testing clinical
trials; (g) identification of genes involved in conferring drug sensitivity
and resistance; and (h) prediction of patients most likely to benefit from
the drug and use in general pharmacogenomic studies. As a result of furthe
r technological improvements and decreasing costs, the use of microarrays w
ill become an essential and potentially routine tool for cancer and biomedi
cal research. (C) 2001 Elsevier science Inc. All rights reserved.